Read About Our Work and Products in the Literature
Alexander A. Cohen, Jennifer R. Keeffe ... Pamela J. Bjorkman
Division of Biology and Biological Engineering, California Institute of Technology
​
Immunization with mosaic-8b nanoparticles, which present eight SARS-like betacoronavirus (sarbecovirus) RBDs, elicits broader cross-reactive antibodies compared to SARS-CoV-2 RBD-only nanoparticles and offers protection against diverse sarbecoviruses. This study examined how prior COVID-19 vaccinations influence the immune response to mosaic-8b, finding that it induces more de novo antibodies targeting variant RBDs, supporting its potential to protect vaccinated or infected individuals from future SARS-CoV-2 variants and zoonotic sarbecoviruses.
Sai Nikhil Subraveti, Brian K. Wilson, Navid Bizmark, Jason Liu, Robert K. Prud'homme
Department of Chemical and Biological Engineering, Princeton University
A detailed protocol for synthesizing lipid nanoparticles (LNPs) using confined impinging jet (CIJ) mixer technologies, including a two-jet CIJ and a four-jet multi-inlet vortex mixer (µMIVM), is demonstrated. The CIJ mixers generate reproducible, turbulent micro-mixing environments, resulting in the production of monodisperse LNPs.
​
Department of Chemistry, Louisiana State University
​
This work presents an automated extruder designed to enhance undergraduate research by providing a user-friendly system for preparing vesicles, such as liposomes, with precise size and polydispersity control. The project breaks down the development into software, hardware, and testing components, offering students hands-on experience with an accessible, simplified version of an industrial process, with all resources freely available online for further exploration and contribution.
​
Institute for Medical Engineering and Science, Massachusetts Institute of Technology
​
This study used computational methods to design nanoparticles displaying SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs) with various mutations to enhance cross-reactive antibody responses. Among the designed antigens, mosaic-7COM elicited higher binding and neutralization titers in mice compared to other constructs, showing promise for protecting against highly mutated SARS-CoV-2 variants and zoonotic sarbecoviruses.